Renaissance Capital logo

SOPH News

US IPO Weekly Recap: Life sciences, software, and more ride the summer wave in a 19 IPO week

ABSI

IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs submitted initial filings. Protein therapy platform Absci (ABSI) priced at the midpoint to raise...read more

Swiss health tech company SOPHiA GENETICS prices US IPO at $18 midpoint

SOPH

SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, raised $234 million by offering 13 million shares at $18, within the range of $17 to $19. SOPHiA GENETICS provides a cloud-based software-as-a-service (SaaS) platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic...read more

Swiss health tech company SOPHiA GENETICS sets terms for $234 million US IPO

SOPH

SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, announced terms for its IPO on Monday. The Saint-Sulpice, Switzerland-based company plans to raise $234 million by offering 13 million shares at a price range of $17 to $19. The company plans to raise an additional $20 million in a concurrent private placement to an affiliate of GE Healthcare....read more

Swiss health tech company SOPHiA GENETICS files for a $100 million US IPO

SOPH

SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, filed on Friday with the SEC to raise up to $100 million. SOPHiA GENETICS provides a cloud-based software-as-a-service (SaaS) platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. In 2014, the company launched...read more

Archived Headlines